Oct 23 (Reuters) - Biocryst Pharmaceuticals Inc:
* Emergency use authorization granted for Biocryst Pharmaceuticals Inc
Peramivir
* Biocryst and FDA say US cdc has issued emergency use authorization or the
investigational anti-viral drug intravenous Peramivir in some adult and
pediatric hospital patients with confirmed or suspected 2009 h1n1 influenza
infection
* Says has has donated and transferred to the department of health and human
services (hhs) an initial supply sufficient for 1,200 courses of i.v.
peramivir 600 mg once-daily for five days
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Biocryst Pharmaceuticals Inc click here:) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Emergency use authorization granted for Biocryst Pharmaceuticals Inc
Peramivir
* Biocryst and FDA say US cdc has issued emergency use authorization or the
investigational anti-viral drug intravenous Peramivir in some adult and
pediatric hospital patients with confirmed or suspected 2009 h1n1 influenza
infection
* Says has has donated and transferred to the department of health and human
services (hhs) an initial supply sufficient for 1,200 courses of i.v.
peramivir 600 mg once-daily for five days
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Biocryst Pharmaceuticals Inc click here:) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2009 AFX News
